PembrolizumabStevens-Johnson syndrome/toxic epidermal necrolysis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1828卷 / 1期

关键词：

D O I：

10.1007/s40278-020-85493-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：417 / 417

相关论文

共 50 条

[1] PembrolizumabStevens-Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 441 - 441
[2] Cisplatin/pembrolizumabStevens-Johnson syndrome/toxic epidermal necrolysis and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1982 (1) : 131 - 131
[3] PembrolizumabStevens-Johnson syndrome and toxic epidermal necrolysis: 2 case reports
[J]. Reactions Weekly, 2017, 1667 (1) : 270 - 270
[4] Atezolizumab/pembrolizumabStevens-Johnson syndrome and toxic epidermal necrolysis: 2 case reports
[J]. Reactions Weekly, 2021, 1842 (1) : 71 - 71
[5] PembrolizumabStevens-Johnson Syndrome: case report
[J]. Reactions Weekly, 2018, 1728 (1) : 291 - 291
[6] PembrolizumabStevens-Johnson syndrome : case report
[J]. Reactions Weekly, 2023, 1984 (1) : 443 - 443
[7] PembrolizumabStevens-Johnson syndrome: case report
[J]. Reactions Weekly, 2019, 1766 (1) : 240 - 240
[8] PembrolizumabStevens Johnson syndrome and toxic epidermal necrolysis: 3 case reports
[J]. Reactions Weekly, 2017, 1655 (1) : 199 - 199
[9] PembrolizumabStevens-Johnson syndrome and thyroiditis: case report
[J]. Reactions Weekly, 2021, 1851 (1) : 293 - 293
[10] PembrolizumabStevens-Johnson syndrome
[J]. Reactions Weekly, 2024, 2012 (1) : 303 - 303

← 1 2 3 4 5 →